Literature DB >> 25108915

Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.

Bradley D Allen1, Lubna Choudhury2, Alex J Barker3, Pim van Ooij3, Jeremy D Collins3, Robert O Bonow2, James C Carr3, Michael Markl4.   

Abstract

AIMS: The left ventricular outflow tract (LVOT) peak pressure gradient is an important haemodynamic descriptor in patients with hypertrophic cardiomyopathy (HCM); however, secondary alterations in aortic blood flow have not been well described in these patients. Aortic flow derangement is not easily assessed by traditional imaging methods, but may provide unique characterization of this disease. In this study, we demonstrated how four-dimensional (4D) flow MRI can assess LVOT peak pressure gradients in HCM patients and also evaluated the ascending aorta (AAo) haemodynamic derangement associated with HCM. METHODS AND
RESULTS: Obstructive (n = 12) and non-obstructive (n = 18) HCM patients were included in the study along with 10 normal volunteers. 4D flow MRI was used to visualize three-dimensional (3D) blood flow patterns within the LVOT and AAo, which were graded for the presence of helical flow as a marker of flow derangement (absent = 0, mild/moderate = 1, and severe = 2). MRI-estimated pressure gradient (ΔPMRI) was calculated from the peak systolic 3D blood velocity profile within the LVOT. There was higher grade helical flow in obstructive HCM patients compared with non-obstructive patients (P = 0.04) and volunteers (P < 0.001). Non-obstructive patients also had higher helix grade than volunteers (P = 0.002). There was a significant correlation between helical grade and increasing ΔPMRI (rS = 0.69, P < 0.001). Systolic anterior motion (SAM) of the mitral valve was associated with both increasing helix grade (P < 0.001) and ΔPMRI (P = 0.006).
CONCLUSIONS: Ascending aorta flow derangement occurs in both obstructive and non-obstructive HCM patients and can be identified using 4D flow MRI. The degree of flow derangement correlates with LVOT gradient, SAM, and outflow tract geometry. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Flow imaging; Hypertrophic cardiomyopathy

Mesh:

Year:  2014        PMID: 25108915      PMCID: PMC4366608          DOI: 10.1093/ehjci/jeu146

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  35 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

3.  Four-dimensional velocity-encoded magnetic resonance imaging improves blood flow quantification in patients with complex accelerated flow.

Authors:  Sarah Nordmeyer; Eugénie Riesenkampff; Daniel Messroghli; Siegfried Kropf; Johannes Nordmeyer; Felix Berger; Titus Kuehne
Journal:  J Magn Reson Imaging       Date:  2012-09-13       Impact factor: 4.813

4.  Doppler evidence that true left ventricular-to-aortic pressure gradients exist in hypertrophic cardiomyopathy.

Authors:  P C Come; M F Riley; L V Carl; B Lorell
Journal:  Am Heart J       Date:  1988-11       Impact factor: 4.749

5.  Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy.

Authors:  A Guarise; N Faccioli; G Foti; S Da Pozzo; P Meneghetti; G Morana
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

6.  Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction.

Authors:  Jens Vogel-Claussen; Miguel Santaularia Tomas; Amit Newatia; Danielle Boyce; Aurelio Pinheiro; Roselle Abraham; Theodore Abraham; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2012-05-01       Impact factor: 4.813

7.  Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.

Authors:  Stefano Nistri; Iacopo Olivotto; Martin S Maron; Camilla Grifoni; Katia Baldini; Massimo Baldi; Aurelio Sgalambro; Franco Cecchi; Barry J Maron
Journal:  Am J Cardiol       Date:  2010-09-21       Impact factor: 2.778

8.  Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.

Authors:  Thananya Boonyasirinant; Prabhakar Rajiah; Randolph M Setser; Michael L Lieber; Harry M Lever; Milind Y Desai; Scott D Flamm
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

9.  Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR.

Authors:  Jonas Bürk; Philipp Blanke; Zoran Stankovic; Alex Barker; Maximilian Russe; Julia Geiger; Alex Frydrychowicz; Mathias Langer; Michael Markl
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-13       Impact factor: 5.364

10.  4D flow magnetic resonance imaging in bicuspid aortic valve disease demonstrates altered distribution of aortic blood flow helicity.

Authors:  R Lorenz; J Bock; A J Barker; F von Knobelsdorff-Brenkenhoff; W Wallis; J G Korvink; M M Bissell; J Schulz-Menger; M Markl
Journal:  Magn Reson Med       Date:  2013-05-28       Impact factor: 4.668

View more
  10 in total

Review 1.  The role of magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Edward T D Hoey; Mohamed Elassaly; Arul Ganeshan; Richard W Watkin; Helen Simpson
Journal:  Quant Imaging Med Surg       Date:  2014-10

2.  4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.

Authors:  Aakash N Gupta; Gilles Soulat; Ryan Avery; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-01       Impact factor: 2.357

3.  Hypertrophic Cardiomyopathy Is Associated with Altered Left Ventricular 3D Blood Flow Dynamics.

Authors:  Judith T Pruijssen; Bradley D Allen; Alex J Barker; Robert O Bonow; Lubna Choudhury; James C Carr; Michael Markl; Pim van Ooij
Journal:  Radiol Cardiothorac Imaging       Date:  2020-02-27

4.  Efficient method for volumetric assessment of peak blood flow velocity using 4D flow MRI.

Authors:  Michael J Rose; Kelly Jarvis; Varun Chowdhary; Alex J Barker; Bradley D Allen; Joshua D Robinson; Michael Markl; Cynthia K Rigsby; Susanne Schnell
Journal:  J Magn Reson Imaging       Date:  2016-05-18       Impact factor: 4.813

5.  4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.

Authors:  Pim van Ooij; Bradley D Allen; Carla Contaldi; Julio Garcia; Jeremy Collins; James Carr; Lubna Choudhury; Robert O Bonow; Alex J Barker; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2015-07-31       Impact factor: 4.813

6.  Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Monika Gawor; Agata Kubik; Ewa Kowalik; Barbara Miłosz-Wieczorek; Maciej Dąbrowski; Konrad Werys; Łukasz Mazurkiewicz; Katarzyna Kożuch; Magdalena Polańska-Skrzypczyk; Joanna Petryka-Mazurkiewicz; Anna Klisiewicz; Zofia T Bilińska; Jacek Grzybowski; Adam Witkowski; Magdalena Marczak
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-21       Impact factor: 5.364

Review 7.  Recent Advances in Understanding and Managing Cardiomyopathy.

Authors:  Paulino Alvarez; Wh Wilson Tang
Journal:  F1000Res       Date:  2017-09-07

Review 8.  The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy.

Authors:  Sanjay Sivalokanathan
Journal:  Diagnostics (Basel)       Date:  2022-01-26

9.  Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.

Authors:  Aakash N Gupta; Ryan Avery; Gilles Soulat; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz
Journal:  J Cardiovasc Magn Reson       Date:  2021-12-06       Impact factor: 5.364

10.  Dysregulation of Endothelial Nitric Oxide Synthase Does Not Depend on Hemodynamic Alterations in Bicuspid Aortic Valve Aortopathy.

Authors:  Simon Gauer; Brittany Balint; Catherine Kollmann; Jan M Federspiel; Dominic Henn; Doris Bandner-Risch; Wolfram Schmied; Hans-Joachim Schäfers
Journal:  J Am Heart Assoc       Date:  2020-09-02       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.